Highlights |
|
Several "What's New" factors will help dermatologists optimize photodynamic therapy in the treatment of actinic keratoses.
Read how. |
|
Neal Bhatia, M.D., asked attendees to consider why they treat AKs and challenged them to think of more strategies for preventing and minimizing treatment problems. His challenge. |
The latest on AK tx |
|
Dr. Neal Bhatia shares his opinion on why routine eradication of AKs is necessary but controversial, and why dermatologists need to treat through the disease. What he has to say. |
|
Short ALA incubation coupled with blue light therapy yields effective, pain-free results. How pain scores compare. |
FOLLOW US ON TWITTER |
|
Follow us at @DermTimesNow
to engage with us about the show.
|
|
|
We welcome your feedback!
Please send your comments to:
Heather Onorati
Group Content Director
Dermatology Times
honorati@advanstar.com |
DISCLAIMER:
This information has been independently developed and provided by the editors of Dermatology Times. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
